secwatch.observer — SEC 8-K summary
======================================

Issuer:     COGNITION THERAPEUTICS INC (CGTX)
CIK:        0001455365
Form:       8-K
Filed at:   2026-06-18T12:05:18+00:00
Accession:  0001104659-26-075442
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Cognition Therapeutics stockholders elect Fletcher and Ricciardi as Class II directors, ratify Ernst & Young as auditor
--------------------------------------------------------------------------------

- Aaron Fletcher, Ph.D. elected with 15,093,537 votes for, 680,677 withheld, 34,035,661 broker non-votes.
- Lisa Ricciardi elected with 15,094,238 votes for, 679,976 withheld, 34,035,661 broker non-votes.
- Ratification of Ernst & Young as independent auditor for 2026: 49,039,407 for, 126,951 against, 643,517 abstentions.
- Annual meeting held June 17, 2026; all proposals passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1455365/000110465926075442/0001104659-26-075442-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1455365/000110465926075442/tm2618236d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-075442

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer